Skip to main content
Log in

Atypical antipsychotics, clozapine and sulpiride do not antagonise amphetamine-induced stereotyped locomotion

  • Original Investigations
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

An automated tracking system which converted an animal's path between quadrants of a circular open field into a series of trips was used to analyse stereotyped locomotion in amphetamine treated rats. Amphetamine (3.5 mg/kg) increased the horizontal distance moved and the number and proportion of thigmotaxic trips around the perimeter of the apparatus (length 4 trips). To investigate the hypothesis that classic antipsychotics, but not atypical antipsychotics, would antagonise the repetitive boundary patrolling associated with amphetamine-induced hyperactivity, animals were pretreated with haloperidol (0.01, 0.025, 0.05, 0.075 mg/kg), clozapine (5, 10, 20 mg/kg) or (±)sulpiride (10, 20, 50 mg/kg) 30 min before 3.5 mg/kg amphetamine. The results showed that the classic antipsychotic haloperidol antagonised both hyperactivity and the increased proportion of length 4 trips. In marked contrast, the atypical antipsychotics clozapine and sulpiride antagonised hyperactivity but did not reduce the proportion of length 4 trips. The inability of atypical antipsychotics to reduce the repetitive boundary patrolling associated with amphetamine-induced hyperactivity is consistent with the action of these drugs on other forms of amphetamine-induced stereotyped behaviour, and indicates that locomotor routes under amphetamine are stereotyped. The measurement of trip lengths provides a sensitive tool for examining drug action on the spatial distribution of open field locomotion.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Costall B, Domeney AM, Naylor RJ, Tyers MB (1987) Effects of the 5-HT3 receptor antagonist, GR38032F, on raised dopaminergic activity in the mesolimbic system of the rat and marmoset brain. Br J Pharmacol 92:881–894

    Google Scholar 

  • Creese I, Iversen SD (1975) The pharmacological and anatomical substrates of the amphetamine response in the rat. Brain Res 83:419–436

    Google Scholar 

  • Geyer MA (1990) Approaches to the characterization of drug effects on locomotor activity in rodents. In: Alder MW, Cowan A (eds) Modern methods in pharmacology vol 6. Testing and evaluation of drugs of abuse. Wiley-Liss, New York, pp 81–99

    Google Scholar 

  • Geyer MA, Russo PV, Segal DS, Kuczenski R (1987) Effects of apomorphine and amphetamine on patterns of locomotor and investigatory behaviour in rats. Pharmacol Biochem Behav 28:393–399

    Google Scholar 

  • Green AR, Costain DW (1981) Pharmacology biochemistry of psychiatric disorders. Wiley, New York, pp 104–128

    Google Scholar 

  • Howell DC (1982) Statistical methods for psychology, 2nd edn. Duxbury Press, Boston

    Google Scholar 

  • Kelly PH, Seviour PW, Iversen SD (1975) Amphetamine and apomorphine responses in the rat following 6-OHDA lesions of the nucleus accumbens septi and corpus striatum. Brain Res 94:507–522

    Google Scholar 

  • Kenyon P (1990) TRACKER: computer assisted analysis of animal motor activity. Laboratory Microcomputer 9:50–59

    Google Scholar 

  • Kenyon P (1991) STEREO: a program to analyse stereotyped open field locomotion. Curr Psychol Res Rev 9[4]:333–337

    Google Scholar 

  • Kenyon P, Moore S, Hampson J (1992) Effect of sulpiride on amphetamine-induced activity and stereotyped locomotion. Curr Psychol Res Rev 11:241–253

    Google Scholar 

  • Ljungberg T, Ungerstedt U (1978) Classification of neuroleptic drugs according to their ability to inhibit apomorphine-induced locomotion and gnawing: evidence for two different mechanisms of action. Psychopharmacology 56:239–247

    Google Scholar 

  • Ljungberg T, Ungerstedt U (1985) A rapid and simple behavioural screening method for simultaneous assessment of limbic and striatal blocking effects of neuroleptic drugs. Pharmacol Biochem Behav 23:479–485

    Google Scholar 

  • Lyon M, Robbins T (1975) The action of central nervous system drugs: a general theory concerning amphetamine effects. In: Essman W, Valzelli L (eds) Current developments in psychopharmacology, vol. 2. Spectrum, New York, pp 79–163

    Google Scholar 

  • Mueller K, Hollingsworth EM, Cross DR (1989a) Another look atd-amphetamine-induced stereotyped locomotor activity in rats using a new statistic to measure locomotor stereotypy. Psychopharmacology 97:74–79

    Google Scholar 

  • Mueller K, Kunko PM, Whiteside D, Haskett C (1989b) Time course of amphetamine-induced locomotor stereotypy in an open field. Psychopharmacology 99:501–507

    Google Scholar 

  • Paulus MP, Geyer MA (1991) A temporal and spatial scaling hypothesis for the behavioral effects of psychostimulants. Psychopharmacology 104:6–16

    Google Scholar 

  • Paulus MP, Geyer MA, Gold LH, Mandell AJ (1988) Assessing complexity of rat locomotor behaviour using invariant measures from ergodic theory. Soc Neurosci Abstr 14:221

    Google Scholar 

  • Pijnenburg AJJ, Van Rossum JM (1973) Stimulation of locomotor activity following injection of dopamine into the nucleus accumbens. J Pharm Pharmacol 25:1003–1005

    Google Scholar 

  • Rebec GV, Bashore T (1984) Critical issues in assessing the behavioural effects of amphetamine. Neurosci Biobehav Rev 8:153–159

    Google Scholar 

  • Robertson A, MacDonald C (1984) Atypical neuroleptics clozapine and thioridazine enhance amphetamine-induced stereotypy. Pharmacol Biochem Behav 21:97–101

    Google Scholar 

  • Robertson A, MacDonald C (1985) Opposite effects of sulpiride and metoclopromide on amphetamine-induced stereotypy. Eur J Pharmacol 36:181–188

    Google Scholar 

  • Schiorring E (1979) Study of the stereotyped locomotor activity in amphetamine treated rats. Psychopharmacology 66:281–287

    Google Scholar 

  • Schremmer C, Morgenstern R, Fink H, Ott T (1990) Atypical neuroleptics suppress dopaminergic behavioural supersensitivity. Psychopharmacology 100:399–403

    Google Scholar 

  • Sharp T, Zetterstrom T, Ljungberg T, Ungerstedt U (1986) Effect of sulpiride on amphetamine-induced behaviour in relation to changes in spatial dopamine release in vivo. Eur J Pharmacol 129:411–415

    Google Scholar 

  • Szechtman H, Eilam D, Teitelbaum P, Golani I (1988) A different look at measurement and interpretation of stereotyped behaviour. Psychobiology 16:164–173

    Google Scholar 

  • Tamminga CA, Gerlach J (1987) New neuroleptics and experimental antipsychotics in schizophrenia. In: Meltzer HY (ed) Psychopharmacology: the third generation of progress. Raven, New York, pp 1129–1139

    Google Scholar 

  • Tschanz JT, Rebec GV (1989) Atypical antipsychotic drugs block selective components of amphetamine-induced stereotypy. Pharmacol Biochem Behav 31:519–522

    Google Scholar 

  • White IM, Ciancone MT, Haracz JL, Rebec GV (1992) A lever-release version of the conditioned avoidance response paradigm: effects of haloperidol, clozapine, sulpiride, and BMY-14802. Pharmacol Biochem Behav 41:29–35

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Moore, S., Kenyon, P. Atypical antipsychotics, clozapine and sulpiride do not antagonise amphetamine-induced stereotyped locomotion. Psychopharmacology 114, 123–130 (1994). https://doi.org/10.1007/BF02245453

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02245453

Key words

Navigation